AzTrials
AzTrials

Dissociative Identity Disorder (DID)EXPLO-DIDNCT07663890

EXPLOration of Processes Involved in Dissociative Identity Disorder (DID)

An observational study of Dissociative Identity Disorder (DID), run by Lille University at 4 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Dissociative Identity Disorder (DID) is a psychological condition in which a person may feel as though they have multiple distinct personalities or identities. Today, this disorder is being discussed more and more, particularly among young people, partly due to its visibility on social media. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Dissociative Identity Disorder (DID)
What is being tested?
Questionnaire and Physical Exam and Interview
How many people
60 participants
Where
4 sitesFrance
Study dates
4 Jun 2026to 30 Jun 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: People who report suffering from Dissociative Identity Disorder (DID).

Who may be able to join

  • Individuals who report having Dissociative Identity Disorder (DID)
  • At least 18 years old
  • Currently receiving treatment from a therapist (psychologist or psychiatrist)

Who cannot join

  • Individuals under guardianship or court-ordered protection

Trial locations and contacts

4 sites in 1 country. Contact the study team or a site near you to ask about taking part.

France4 sites, 4 recruiting
  • Sophie Marek's Practice

    Carvin

    Marek, 003006 30 72 98 82, sophie.marek@univ-lille.fr

    Sophie Marek, psychologist

    Recruiting
  • Online Consultation Cabinet

    Chambray-lès-Tours

    Elorriaga, 003306 52 59 38 45, celorriaga@proton.me

    Cécile Elorriaga, psychologist

    Recruiting
  • Online Consultation Cabinet - Alexis VANCAPPEL,

    Lille, 59800

    VANCAPPEL, 00336 61 26 36 02, alexis.vancappel@univ-lille.fr

    Alexis VANCAPPEL, PhD

    Recruiting
  • Centre Régional du Psychotraumatisme

    Tours

    El-Hage, 0033 02 47 47 71 11, wissam.elhage@univ-tours.fr

    William El-Hage, Dr, PhD

    Recruiting

Other trials in France

About this study

Official title: EXPLOration Des Processus à l'Origine du Trouble Dissociatif de l'Identité (TDI)(EXPLOTDI)

Dissociative Identity Disorder (DID) is a psychological condition in which a person may feel as though they have multiple distinct personalities or identities. Today, this disorder is being discussed more and more, particularly among young people, partly due to its visibility on social media. However, researchers have observed that some individuals may mimic or exaggerate the symptoms, which makes it more difficult to understand the disorder.

The goal of this study is therefore to better understand:

Read more
  • in which situations these identity shifts occur
  • what people feel at that moment
  • and what happens next To do this, researchers will interview approximately 60 people, some with a diagnosed DID and others exhibiting simulated symptoms.

Participants will complete questionnaires and take part in an interview. The researchers will analyze:

  • the situations that trigger the changes
  • the associated thoughts and emotions
  • the behaviors
  • the consequences of these episodes

The ultimate goal is to better understand this disorder in order to:

  • improve care
  • and better distinguish between genuine cases and feigned ones
Read the detailed description

This study falls within the field of dissociative disorders, and more specifically dissociative identity disorder (DID), whose clinical validity and mechanisms remain controversial, particularly due to the reported frequency of feigned symptoms.

Objective The primary objective is to identify the functional determinants of episodes of personality state change, whether genuine or feigned, within the framework of cognitive-behavioral therapies (CBT).

The analysis is based on the SORC functional model:

  • S (Stimuli): triggering situations
  • O (Organism): cognitions, emotions, sensations, imagery
  • R (Response): operant behaviors
  • C (Consequences): short- and long-term effects Methodology An exploratory qualitative approach will be used, aimed at generating hypotheses for subsequent quantitative research.

Participants

  • N ≈ 60
  • 30 diagnosed with TDI
  • 30 simulated TDI
  • Multicenter recruitment
  • Inclusion: ≥ 18 years old, currently undergoing therapy Procedure

Participants will complete:

  • sociodemographic questionnaires
  • standardized scales:
  • dissociation (sDIS-Q)
  • dissociative beliefs (DSB)
  • knowledge about dissociation (KADS)
  • post-traumatic symptoms Then, a semi-structured qualitative interview will be conducted and recorded. Analysis
  • Thematic analysis of interviews
  • Data saturation approach
  • Cross-coding by raters Scientific objectives
  • Clarify the mechanisms of TDI
  • Identify functional patterns of dissociative episodes
  • Explore differences between genuine and feigned symptoms
  • Improve diagnostic validity and therapeutic interventions
Being tested
Questionnaire and Physical Exam, Interview
Keywords
Dissociative Identity Disorder
Medical subject headings
Dissociative Identity Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Questionnaire and Physical ExamOther

    5 standardized assessment tools measuring, respectively, dissociation (sDIS-Q; Vancappel, Chkili, et al., 2025), beliefs about dissociation (DSB; Vancappel et al., 2023), knowledge and skills related to dissociation (KADS; Vancappel, Chami, et al., 2025), psychotrauma (Ashbaugh et al., 2016), and dissociation simulation.

  • InterviewOther

    qualitative interview with the therapist they are already seeing

Study groups in NCT07663890
Study groupRoleWhat they receive
Patientspatients diagnosticated with DDI or simulating DDI
Receives: Other: Questionnaire and Physical Exam; Other: Interview
Patients' families and loved onesthe patients' families and loved ones
Receives: Other: Questionnaire and Physical Exam; Other: Interview

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dissociative symptoms

    Questionnaire

    Measured: baseline

  2. Beliefs about dissociation

    Questionnaire

    Measured: baseline

  3. Skills and knowledge regarding dissociation

    Questionnaire

    Measured: baseline

  4. Psychotraumatic symptoms

    Questionnaire

    Measured: baseline

  5. How the TDI Works

    Qualitative interview

    Measured: baseline

  6. Simulation

    Qualitative interview

    Measured: baseline

  7. Dissociative symptoms

    Qualitative interview

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jun 2026
  2. Study start4 Jun 2026
  3. Primary completion30 Jun 2026 (estimated)
  4. Study completion30 Jun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07663890
Sponsor's protocol ID
D2025-6
Other IDs
2025-A02614-45
Acronym
EXPLO-DID
Status last verified
Jun 2026
First submitted
10 Jun 2026
Last updated
26 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Dissociative Identity Disorder (DID), run by Lille University at 4 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dissociative symptoms (time frame: baseline). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in